Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LY 191145

Known as: LY-191145, LY191145 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Vancomycin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.
LY191145 is an N-alkylated glycopeptide antibiotic (the p-chlorobenzyl derivative of LY264826) with activity against vancomycin… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices?
The widespread appearance of methicillin resistant Staphylococcus aureus (MRSA) has significantly undermined the efficacy of… Expand
Is this relevant?
1996
1996
Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic.
LY191145 is a p-chlorobenzyl derivative of LY264826 (A82846B) with activity against both vancomycin-susceptible and -resistant… Expand
Is this relevant?
1996
1996
Erratum: Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria (Antimicrobial Agents and Chemotherapy 39:1 (2585))
 
Is this relevant?
1995
1995
Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.
LY191145 is the prototype of a series of compounds with activities against vancomycin-resistant enterococci derived by… Expand
Is this relevant?
1995
1995
Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots.
Bactericidal activities of LY191145, an investigational glycopeptide, and vancomycin against Staphylococcus aureus were evaluated… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE